Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bayer AG buy Bulli09

Start price
€51.83
26.01.21 / 70%
Target price
€65.00
26.01.22
Performance (%)
-2.20%
End price
€50.69
27.01.22
Summary
This prediction ended on 27.01.22 with a price of €50.69. With a performance of -2.20%, the BUY prediction by Bulli09 finished with a loss. A total of €2.00 was paid as dividends for this prediction. Bulli09 has 70% into this prediction

Bayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.

Performance without dividends (%)
Name 1w 1m 1y 3y
Bayer AG 2.664% 2.664% -55.184% -50.695%
iShares Core DAX® 1.051% -1.833% 12.822% 15.392%
iShares Nasdaq 100 -0.547% -3.738% 40.625% 42.396%
iShares Nikkei 225® -1.778% -8.115% 16.092% 0.891%
iShares S&P 500 0.002% -2.226% 28.387% 41.095%

Comments by Bulli09 for this prediction

In the thread Bayer AG diskutieren
Prediction Buy
Perf. (%) -2.20%
Target price 65.000
Change
Ends at

Buy mit Kursziel 65,0

In the thread Trading Bayer AG
Prediction Buy
Perf. (%) -2.20%
Target price 65.000
Change
Ends at 26.01.22

Die von Bulli09 gewählte maximale Laufzeit wurde überschritten